title: Patient selection for cardiac resynchronization therapy: from the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society.
abstract: Cardiac resynchronization therapy (CRT) is a relatively new therapy for patients with symptomatic heart failure resulting from systolic dysfunction. CRT is achieved by simultaneously pacing both the left and right ventricles. Biventricular pacing resynchronizes the timing of global left ventricular depolarization and improves mechanical contractility and mitral regurgitation. Published clinical trials have demonstrated that CRT results in improved clinical status and lower mortality rate when selected patients with systolic ventricular dysfunction and heart failure are treated with CRT. This advisory identifies appropriate candidates for CRT on the basis of the inclusion criteria and results from the published clinical trials.
authors.forename: S Adam
authors.initials: SA
authors.lastname: Strickberger
authors.forename: Jamie
authors.initials: J
authors.lastname: Conti
authors.forename: Emile G
authors.initials: EG
authors.lastname: Daoud
authors.forename: Edward
authors.initials: E
authors.lastname: Havranek
authors.forename: Mandeep R
authors.initials: MR
authors.lastname: Mehra
authors.forename: Ileana L
authors.initials: IL
authors.lastname: Piña
authors.forename: James
authors.initials: J
authors.lastname: Young
mesh_terms: D001145:Arrhythmias, Cardiac / Q000628:therapy; D002304:Cardiac Pacing, Artificial / Q000009:adverse effects / Q000379:methods*; D006333:Heart Failure / Q000628:therapy; D006352:Heart Ventricles; D006801:Humans; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D016896:Treatment Outcome